Ai tool predicts survival after early colon cancer surgery
Part of Cancer, Digestive system clinical trials.
This study uses a computer model to predict how long someone with early-onset colorectal cancer might live after surgery. By joining, you might help improve these predictions for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of early-onset colorectal cancer (cancer that starts in the colon or rectum).
- You must have had surgery to remove the cancer, like a partial or full removal of the colon.
- Your cancer must be stage 1, 2, or 3 (it has not spread to distant parts of the body).
- You must not have had other cancers or multiple primary cancers.
- You must have at least one month of follow-up information after surgery, so the researchers can see how you are doing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
This study tests a new tool that helps doctors predict whether a large colon polyp is cancerous. It may help avoid unnecessary surgery and guide safer removal decisions.
This trial looks at how your immune cells change before and after surgery for colorectal cancer, and whether those changes affect your long-term recovery. It may help doctors predict outcomes and improve care.
This trial is for people with early-stage colon cancer (stage II high-risk or stage III low-risk) that is not MSI-H. It uses a blood test (MRD) to see if you can safely delay or skip extra chemotherapy after surgery, based on whether the test finds any leftover cancer cells.
This study is testing a new way to help doctors better detect colorectal cancer by building a model that uses your risk factors and colonoscopy results. If you join, you'll answer a questionnaire and let the researchers use your routine colonoscopy and medical data to improve this model.
This study uses artificial intelligence to analyze tissue samples from your colorectal cancer surgery to help predict how you'll recover and what your long-term outlook might be. Researchers will examine your tumor tissue under a microscope to build a computer model that could help doctors personalize your care plan.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.